Last update 14 Feb 2026

Anti-CD3/Anti-CD28 combination T cell therapy(University of Michigan)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms-
Target
CD28 x CD3
Action
inhibitors
Mechanism
CD28 inhibitors(T-cell-specific surface glycoprotein CD28 inhibitors), CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
MelanomaRenal Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Originator Organization
University of MichiganUniversity of Michigan
Active Organization-
Inactive Organization
University of MichiganUniversity of Michigan
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Anti-CD3/Anti-CD28 combination T cell therapy(University of Michigan)
Login to view more data
100 Translational Medicine associated with Anti-CD3/Anti-CD28 combination T cell therapy(University of Michigan)
Login to view more data
100 Patents (Medical) associated with Anti-CD3/Anti-CD28 combination T cell therapy(University of Michigan)
Login to view more data
100 Deals associated with Anti-CD3/Anti-CD28 combination T cell therapy(University of Michigan)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPreclinical
United States
University of MichiganUniversity of Michigan
01 Feb 1999
Renal Cell CarcinomaPreclinical
United States
University of MichiganUniversity of Michigan
01 Feb 1999
Squamous Cell Carcinoma of Head and NeckPreclinical
United States
University of MichiganUniversity of Michigan
01 Feb 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free